Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Psychopharmacology > Chapter 2: Transporters, receptors, and enzymes > Flashcards

Chapter 2: Transporters, receptors, and enzymes Flashcards

1
Q

P450 inhibitors: STICKFACES.COM Group

A

S - Sodium valproate
T - Ticlodipine
I - Isoniazid
C - Cimetidine
K - Ketoconazole
F - Fluconazole
A - Acute alcohol/amiodarone
C - Ciprofloxacin
E - Erythromycin
S - Sulfonamides
C - Cranberry juice
O - Omeprazole
M - Metronidazole
Group = grapefruit juice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

P450 Inducers: BS CRAP GPS

A

B - Barbiturates
S - St. John’s Wort
C - Carbamazepine
R - Rifampin
A - Alcohol (chronic)
P - Pheytoin
G - Griseofulvin
P - Phenobarbital
S - Sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

6 most important P450 enzymes

A

1A2
2B6
2D6
2C9
2C19
3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Serotonin transporter and gene family

A

presynaptic monoamine SERT/SLC6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Norepinephrine transporter/gene family

A

presynaptic monoamine NET/SLC6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dopamine transporter/gene family

A

presynaptic monoamine DAT/SLC6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

glial and GABA transporters

A

GAT1-4
GlyT1-2
EAAT1-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GAT1-4 gene family/substrate

A

SLC6/GABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GlyT1-2 gene family/substrate

A

SLC6/Glycine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

EAAT1-5 gene family/substrate

A

SLC1/glutamate and aspartate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

vesicular neurotransmitter transporters VMAT1-2 gene family/substrate

A

SLC18/serotonin
dopamine
histamine
norepinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

VaChT vesicular transporter gene family/substrate

A

SLC18/acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

VIAAT vesicular transporter gene family/substrate

A

SLC32/GABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

vGluT1-3 vesicular transporter gene family/substrate

A

SLC17/glutamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

false substrate for SERT

A

MDMA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

false substrate for NET

A

dopamine, epinephrine, amphetamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

false substrate for DAT

A

norepinephrine, epinephrine, amphetamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

how do transporters concentrate monoamines into presynaptic neurons (reuptake)

A

sodium-potassium ATPase continually pumps sodium out of the cell to create a downhill gradient that allows for the uphill transport of the neurotransmitter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

how do vesicular transporters package neurotransmitters into synaptic vesicles

A

proton ATPase continually pumps positively charged protons out of the vesicles so that the neurotransmitter can be transported into the vesicle to keep the charge the same

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is a neurotransmitter transporter

A

a type of receptor that binds to neurotransmitter prior to transporting it across the membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

2 major classes of plasma membrane transporters

A

sodium/chloride-coupled transporters (SLC6 gene family)
Glutamate transporters (SLC1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

plasma membrane transporters on presynaptic membranes

A

SERT
NET
DAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

plasma membrane transporters located on glia and neuronal cells

A

GAT1-4
BGT1
Gly T1-2
EEAT1-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

SLC6 sodium/chloride-coupled includes which plasma membrane transporters

A

includes transporters for serotonin, norepinephrine, and dopamine as well as the neurotransmitter GABA and amino acid glycine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

presynaptic SLC6 transporters

A

SERT
NET
DAT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

glial SLC6 transporters

A

GAT1-4
BGT1
GlyT1-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

SLC1 glial transporter

A

EAAT1-5 (glutamate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

3 subclasses of intracellular synaptic vesicle transporters

A

SLC18
SLC32
SLC17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what are the two types of molecular transporters

A

plasma membrane transporters
intracellular synaptic vesicle transporters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

SLC18 intracellular synaptic vesicle transporters

A

VMAT1-2 (vesicular monoamine transporters)
VAChT (vesicular acetylcholine transporter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

which monoamines are transported VMAT1-2 intracellular synaptic vesicle transporters

A

serotonin
norepinephrine
dopamine
histamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

SLC32 gene family intracellular synaptic vesicle transporters

A

VIAATs (vesicular inhibitory amino acid transporters)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

SLC17 gene family intracellular synaptic vesicle transporters

A

VGluT1-3 (vesicular glutamate transporters)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

false substrate for SERT presynaptic transporter

A

MDMA (Ecstasy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

false substrates for presynaptic transporter NET

A

dopamine
epinephrine
amphetamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

false substrates for presynaptic transporter DAT

A

norepinephrine, epinephrine, amphetamine

37
Q

synaptic vesicle transporter for all 3 monoamines

A

VMAT2 (vesicular monoamine transporter 2)

38
Q

what are the 3 monoamines

A

sertraline
dopamine
norepinephrine

39
Q

does it take energy to concentrate monoamines into presynaptic neuron?

40
Q

how is energy generated to concentrate monoamines into the presynaptic neuron

A

downhill transport of sodium coupled with uphill transport of the monoamine

41
Q

what does “the sodium pump” (adenosine triphosphatase) do to generate the energy to concentrate monoamines in the presynaptic neuron

A

continuously pumps sodium out of neuron creating a downhill gradient which creates an uphill gradient for the monoamine

42
Q

binding sites on SLC6 transporters

A

2 sodium ion binding sites
other binding sites for drugs (SSRIs)

43
Q

what happens when a drug binds to a receptor on an SLC6 transporter

A

prevents monoamine reuptake

44
Q

what binds to the SLC6 transporter in the absence of sodium

A

nothing; not sodium or monoamine

45
Q

how do you increase monoamine action

A

prevent it from binding to its transporter so it accumulates in the synapse

46
Q

which transporters are blocked by ADHD stimulants and cocaine

47
Q

which tra
nsporters are blocked by most drugs for unipolar depression

A

SERT
NET
DAT

48
Q

what conditions are treated by blocking neurotransmitter transporters

A

anxiety, fibro neuropathic pain, postherpetic neuralgia, peripheral neuropathy and other pain conditions, eating disorders, impulsive-compulsive disorders, OCD, trauma/stress related disorders (PTSD)

49
Q

what condition are NOT treated by blocking monoamine binding to transporters

A

bipolar depression with mixed features

50
Q

what is the only medication that blocks GABA transporter GAT1 to increase synaptic GABA concentration

A

anticonvulsant tiababine

51
Q

what happens when glutamate is transported into glia

A

it is converted into glutamine to enter the presynaptic neuron for conversion back to glutamate

52
Q

differences of SLC1 to SLC6 transporters

A

glutamate is excitatory
exact location on pre/post synaptic neurons/glia is under investigation.
no drugs are known to block them
glutamate transport almost always has countertransport of potassium.
may work as timers rather than dimers

53
Q

transporters for neurotransmitter histamine

A

no presynaptic transporter
vesicular transporter is VMAT2 (same as monoamines)

54
Q

histamines inactivation

A

entirely enzymatic

55
Q

VMATs vesicular transporters are members of what gene family

56
Q

VaChT

A

vesicular transporter for acetylcholine

57
Q

VIAAT is a vesicular transporter that is a member of what gene family

58
Q

what gene family does vesicular transporter vGluT1-3 belong to

A

SLC17
vesicular transporter for glutamate

59
Q

SV2a transporter

A

novel vesicular transporter with 12 transmembrane regions that binds to anticonvulsant levetiracetam whic may reduce seizures by blocking neurotransmitter release

60
Q

how is energy generated to move neurotransmitters into synaptic vesicles

A

proton ATPase (proton pump) pumps positively charged protons out of synaptic vesicles continuously.
neurotransmitters are able to then concentrate against the gradient by substituting their own + charge in the vesicle for the + charge being pumped out
SO
neurotransmitters go in while protons go out, keeping the charge in the vesicle the same

61
Q

which vesicular transporters are NOT known to be targeted by drugs

A

ones for GABA (SLC32), acetylcholine (SLC18), and glutamate (SLC17)

62
Q

which vesicular transporters are targeted by many drugs

A

VMATs (SLC18 family)

63
Q

drugs that target VMAT vesicular transporters

A

amphetamine (both monoamine and vesicular transporters)
methylphenidate and cocaine (only monoamine transporters)
tetrabenzine and its derivatives as inhibitors

64
Q

structure of G-protein-linked receptors

A

7 transmembrane regions (spans membranes 7 tiems) that cluster around a central core that contains a neurotransmitter binding site

65
Q

how do drugs lead to modification of g-protein-linked-receptors

A

they mimick or block neurotransmitter function that normally happens at binding or allosteric sites on the receptor

66
Q

difference between neurotransmitters and drugs on g-protein-linked receptors

A

neurotransmitters interact with all receptor subtypes. Drugs interact only with a specific receptor subtype

67
Q

action of agonists on g-protein-linked receptors

A

turns on the synthesis of the second messenger to the greatest extent possible so downstream proteins are fully phosphorylated and genes are maximally expressed

68
Q

what are the 2 ways to stimulate G-protein-linked receptors with full agonist action

A

drugs bind directly to neurotransmitter sites
or indirectly boost levels of the neurotransmitters themselves

69
Q

2 ways drugs boost levels of neurotransmitters themselves

A

inhibition of monoamine transporters
blocking enzymatic destruction of neurotransmitters

70
Q

2 ways to block enzymatic destruction of neurotransmitters

A

inhibition of SERT, NET, DAT and GABA transporter GAT1

inhibition of enzyme acetylcholinesterase

71
Q

action of antagonist on g-protein-linked receptors

A

produces conformational change in receptor that causes signal transduction to remain at constitutive levels

72
Q

clinical purpose of antagonists on g-protein-linked receptors

A

block excessive neurotransmission
reverses agonists, partial agonists, and inverse agonists

73
Q

action of partial agonists on g-protein-linked receptors

A

produce signal transduction that is more than constitutive but less than agonist depending on how close the partial agonist is to the full agonist

74
Q

action of inverse agonist on g-protein linked receptors

A

causes conformational change to stabilize receptor in inactive form
essentially, turning action down below consitutive

75
Q

what happens when an enzyme is bound

A

it cannot bind with its substrate so it is inactivated
can be reversible or irreversible

76
Q

irreversible binding of an enzyme

A

cannot be displaced by the substrate (essentially killing it)

77
Q

reversible binding of an enzyme

A

when a substrate can compete for the receptor site and shove it off of the enzyme

78
Q

few drugs that bind enzymes used in clinical practice

A

MAOIs
acetylcholinesterase
glycogen synthase kinase (GSK)

79
Q

agents that target GSK enzymes that are used in clinical practice

A

lithium may target in this enzyme in the signal transduction pathway of neurotrophic factors

80
Q

what acts through phosphoprotein GSK-3 to promote cell death

A

neurotrophins, growth factors, and other signaling pathways
it is also possible that valproate and ECT act of GSK3

81
Q

consequences of inhibiting GSK3

A

may have neuroprotective actions, long term plasticity, and may contribute to mood stabilizing effects of lithium

82
Q

what are CYP enzymes

A

drug metabolizing enzymes that are mediated through the liver and gut that are responsible for a large amount of psychotropic drugs

83
Q

are pharmacokinetics or pharmacodynamics responsible for mechanism of action of psychotropic drugs

A

pharmacodynamics

84
Q

6 most important CYP450 enzymes

A

1A2
2B6
2D6
2C9
2C19
3A4

85
Q

extensive metabolizers

A

people who have “normal” rates of drug metabolism by CYP4550 enzymes

86
Q

what happens if there is reduced activity of CYP450 enzymes

A

risk for elevated drug levels as they are not metabolized fast enough
patients need less than standard doses

87
Q

ultra-rapid metabolizers

A

people who have elevated CYP450 enzyme activity

88
Q

consequences of being an ultra-rapid metabolizer

A

may require higher than standard doses due to resultant subtherapeutic drug levels

Psychopharmacology (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions